Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.

@article{Nettis2005ShorttermTO,
  title={Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.},
  author={Eustachio Nettis and Maria Cristina Colanardi and Antonio Ferrannini and Angelo Vacca and Alfredo Tursi},
  journal={Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology},
  year={2005},
  volume={95 5},
  pages={438-42}
}
BACKGROUND Etoricoxib is a novel cyclooxygenase 2 selective inhibitor. Until now, there has not been information in the literature about its tolerability in patients with a history of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). OBJECTIVE To determine the short-term tolerability of etoricoxib in patients with a history of cutaneous adverse reactions to NSAIDs. METHODS Single-blind challenge testing was performed on 2 different days using placebo (talc) and… CONTINUE READING